Literature DB >> 21451107

Opposite effects of endogenous peptide-MHC class I on T cell activity in the presence and absence of CD8.

Jennifer D Stone1, David H Aggen, Adam S Chervin, Samanthi Narayanan, Thomas M Schmitt, Philip D Greenberg, David M Kranz.   

Abstract

Nonstimulatory or endogenous peptide-MHC (pepMHC) presented on the surfaces of APCs, either alone or alongside agonist pepMHC, plays various roles in T cell selection and activation. To examine these properties in more detail, we explored several model systems of TCR and pepMHC ligands with sufficient affinity to be activated in the absence of CD8. The TCRs had a range of affinities for agonist and nonstimulatory ligands and were restricted by MHC class I alleles with different properties. We observed CD8-independent antagonism from TCR-pepMHC interactions with very low affinities (e.g., K(D) = 300 μM). In addition, endogenous peptide-L(d) complexes on APCs antagonized activation of coreceptor (CD8)-negative 2C T cells even by the strong agonist QL9-L(d). In contrast, TCRs m33 and 3D-PYY, restricted by K(b) and D(b), respectively, did not show signs of antagonism by endogenous pepMHC in the absence of CD8. This did not appear to be an inherent difference in the ability of the TCRs to be antagonized, as altered peptide ligands could antagonize each TCR. In the presence of CD8, endogenous pepMHC ligands acted in some cases as coagonists. These results show that endogenous pepMHC molecules exhibit complex behavior in T cells, leading to either reduced activity (e.g., in cases of low coreceptor levels) or enhanced activity (e.g., in presence of coreceptor). The behavior may be influenced by the ability of different TCRs to recognize endogenous pepMHC but also perhaps by the inherent properties of the presenting MHC allele.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21451107      PMCID: PMC3095212          DOI: 10.4049/jimmunol.1003755

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  59 in total

1.  Costimulation and endogenous MHC ligands contribute to T cell recognition.

Authors:  Christoph Wülfing; Cenk Sumen; Michael D Sjaastad; Lawren C Wu; Michael L Dustin; Mark M Davis
Journal:  Nat Immunol       Date:  2001-12-03       Impact factor: 25.606

2.  Quantitative analysis of the contribution of TCR/pepMHC affinity and CD8 to T cell activation.

Authors:  Phillip D Holler; David M Kranz
Journal:  Immunity       Date:  2003-02       Impact factor: 31.745

3.  TCRs with high affinity for foreign pMHC show self-reactivity.

Authors:  Phillip D Holler; Lukasz K Chlewicki; David M Kranz
Journal:  Nat Immunol       Date:  2002-12-09       Impact factor: 25.606

4.  A low affinity TCR ligand restores positive selection of CD8+ T cells in vivo.

Authors:  H E Stefanski; D Mayerova; S C Jameson; K A Hogquist
Journal:  J Immunol       Date:  2001-06-01       Impact factor: 5.422

5.  Rare, structurally homologous self-peptides promote thymocyte positive selection.

Authors:  Fabio R Santori; William C Kieper; Stuart M Brown; Yun Lu; Thomas A Neubert; Kenneth L Johnson; Stephen Naylor; Stanislav Vukmanović; Kristin A Hogquist; Stephen C Jameson
Journal:  Immunity       Date:  2002-08       Impact factor: 31.745

6.  Direct observation of ligand recognition by T cells.

Authors:  Darrell J Irvine; Marco A Purbhoo; Michelle Krogsgaard; Mark M Davis
Journal:  Nature       Date:  2002-10-24       Impact factor: 49.962

7.  Allogeneic and syngeneic class I MHC complexes drive the association of CD8 and TCR on 2C T cells.

Authors:  Peter U Y Lee; David M Kranz
Journal:  Mol Immunol       Date:  2003-01       Impact factor: 4.407

8.  Monomeric class I molecules mediate TCR/CD3 epsilon/CD8 interaction on the surface of T cells.

Authors:  M S Block; A J Johnson; Y Mendez-Fernandez; L R Pease
Journal:  J Immunol       Date:  2001-07-15       Impact factor: 5.422

9.  Peptide-MHC heterodimers show that thymic positive selection requires a more restricted set of self-peptides than negative selection.

Authors:  Jeremy Juang; Peter J R Ebert; Dan Feng; K Christopher Garcia; Michelle Krogsgaard; Mark M Davis
Journal:  J Exp Med       Date:  2010-05-10       Impact factor: 14.307

10.  Partially phosphorylated T cell receptor zeta molecules can inhibit T cell activation.

Authors:  E N Kersh; G J Kersh; P M Allen
Journal:  J Exp Med       Date:  1999-12-06       Impact factor: 14.307

View more
  7 in total

1.  The same major histocompatibility complex polymorphism involved in control of HIV influences peptide binding in the mouse H-2Ld system.

Authors:  Samanthi Narayanan; David M Kranz
Journal:  J Biol Chem       Date:  2013-09-24       Impact factor: 5.157

2.  T cell receptor signaling is limited by docking geometry to peptide-major histocompatibility complex.

Authors:  Jarrett J Adams; Samanthi Narayanan; Baoyu Liu; Michael E Birnbaum; Andrew C Kruse; Natalie A Bowerman; Wei Chen; Aron M Levin; Janet M Connolly; Cheng Zhu; David M Kranz; K Christopher Garcia
Journal:  Immunity       Date:  2011-11-23       Impact factor: 31.745

3.  The discriminatory power of the T cell receptor.

Authors:  Johannes Pettmann; Anna Huhn; Enas Abu Shah; Mikhail A Kutuzov; Daniel B Wilson; Michael L Dustin; Simon J Davis; P Anton van der Merwe; Omer Dushek
Journal:  Elife       Date:  2021-05-25       Impact factor: 8.140

Review 4.  Phenotypic models of T cell activation.

Authors:  Melissa Lever; Philip K Maini; P Anton van der Merwe; Omer Dushek
Journal:  Nat Rev Immunol       Date:  2014-09       Impact factor: 53.106

5.  Cross-TCR Antagonism Revealed by Optogenetically Tuning the Half-Life of the TCR Ligand Binding.

Authors:  Omid Sascha Yousefi; Matias Ruggieri; Vincent Idstein; Kai Uwe von Prillwitz; Laurenz A Herr; Julia Chalupsky; Maja Köhn; Wilfried Weber; Jens Timmer; Wolfgang W A Schamel
Journal:  Int J Mol Sci       Date:  2021-05-06       Impact factor: 5.923

6.  Role of T cell receptor affinity in the efficacy and specificity of adoptive T cell therapies.

Authors:  Jennifer D Stone; David M Kranz
Journal:  Front Immunol       Date:  2013-08-21       Impact factor: 7.561

7.  Coreceptor affinity for MHC defines peptide specificity requirements for TCR interaction with coagonist peptide-MHC.

Authors:  John A H Hoerter; Joanna Brzostek; Maxim N Artyomov; Steven M Abel; Javier Casas; Vasily Rybakin; Jeanette Ampudia; Carina Lotz; Janet M Connolly; Arup K Chakraborty; Keith G Gould; Nicholas R J Gascoigne
Journal:  J Exp Med       Date:  2013-08-12       Impact factor: 14.307

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.